Reid BJ, Li X, Galipeau PC, Vaughan TL
GLP-1 RA Trial Solutions | Signant Health The evolution of patient-reported outcomes (PROs) in early-phase oncology trials Regulatory guidance and sponsor priorities are converging to incorporate PROs into early-phase oncology trial designs, particularly as they offer critical insights into symptomatic adverse events and patient tolerability, which are vital for optimal dose determination and safety evaluation
dactylifera PdGPXs, which showed that PdGPX2, 4, 5 were highly related to homologs in G
Vitamin D Vitamin D is crucial for bone health, immune function and muscle strength
The role and research progress of serine metabolism in tumor cells
GRF (1-29) itself was found to suffer from rapid metabolic clearance, leading to the synthesis of analogues with substituted amino acids more resistant to enzymatic cleavage